SlideShare une entreprise Scribd logo
1  sur  16
Reimagining Eye Care
About Alcon
2 | Alcon Corporate Presentation | July 2016 | Business Use Only
Why We Exist
20 million are blind
from cataracts
1.7 billion have
presbyopia
93 million have
diabetic retinopathy
67 million live
with glaucoma
153 million have
uncorrected
refractive errors
3 | Alcon Corporate Presentation | July 2016 | Business Use Only
We operate in 74 and serve patients in over 140 countries
• Fort Worth, TX, US: Global,
Americas
• Switzerland: Europe, Middle
East and Africa
• Singapore: Asia & Russia
• Japan
Headquarters
• US: Georgia and Texas
• Europe: Germany
• Asia: Singapore, Malaysia,
Indonesia
Vision Care R&D and
Manufacturing
• US: California, Texas,
Pennsylvania, West Virginia
• Europe: Switzerland,
Germany, Ireland, Belgium
• Israel
Surgical R&D and
Manufacturing
4 | Alcon Corporate Presentation | July 2016 | Business Use Only
We are 16,000 people strong
Our workforce comprises individuals from 96 nationalities
Our Values and Behaviors guide the choices we make and actions we take: innovation,
quality, collaboration, performance, courage and integrity
We create meaningful opportunities for associates to grow their careers
5 | Alcon Corporate Presentation | July 2016 | Business Use Only
Discovering new ways to enhance sight for nearly 70 years
1994
AcrySof®
2000 20112007
WaveLight®1947
Alcon
incorporates
2010
LenSx®
2014
1989
CooperVision
surgical
2012 / 2013
DAILIES TOTAL1®
and Centurion®
2015
PanOptix® and
UltraSert®
2016
CyPass ® and
NGenuity ®
1996
FOCUS®
DAILIES®
2004
O2OPTIX ®
(re-branded as AIR
OPTIX® in 2008)
6 | Alcon Corporate Presentation | July 2016 | Business Use Only
In 2015, we reached more
than 260 million
patients
but there are still
285 million
living with low vision and
blindness
Reimagining eye care to address growing patient needs
Aging population with
growing unmet needs
Scientific & technological
innovation are improving
outcomes
Our vision is to be the
trusted leader in eye care
Our mission is to
discover new ways to
enhance sight and
improve people’s lives
7 | Alcon Global Webcast | May 2016 | Business Use Only
The Alcon Experience Standards
Our guiding principles to delight our customers at every touch point
Patients and Consumers First
Partnership
Expertise
8 | Alcon Corporate Presentation | July 2016 | Business Use Only
Together with Novartis, we offer the widest spectrum of
products in eye care
Treating the entire eye
Cornea /
front of eye
Refractive errors,
inflammation,
infection, dry
eye, allergy
Lens
Cataract,
presbyopia
Optic nerve
Glaucoma
Retina / back
of eye
Vitreoretinal /
retinal
diseases
And the full lifecycle of
eye care needs
Infants
Children
Teenagers
Age 60
and up
Age
40-59
Age 20-39
9 | Alcon Corporate Presentation | July 2016 | Business Use Only
Most complete line of ophthalmic surgical devices
#1 Intraocular
Lenses
#1 Cataract
Equipment
#1 Vitreoretinal
Equipment
#2 Refractive
Equipment
New category:
Surgical Glaucoma
AcrySof® IOLs
• 90 mil implants
since 1994
• Astigmatism and
presbyopia correction
• PanOptix® trifocal
IOL
• UltraSert® Pre-
loaded IOL Delivery
System
Cataract Refractive
Suite for superior
outcomes
• Centurion®
• LenSx®
• Verion®
• ORA System®
• LuxOR®
• Consumables
Constellation® Vision
System to effectively
treat retinal conditions
• Superior instruments
and consumables
• NGENUITY® 3D
Visualization System
Wavelight® diagnoses
and corrects myopia,
hyperopia and
astigmatism
• Contoura™ Vision
Topography-Guided
primary LASIK
treatments
CyPass® minimally-
invasive micro-stent to
treat glaucoma
• CE Mark in Europe;
FDA approved
10 | Alcon Corporate Presentation | July 2016 | Business Use Only
Differentiated contact lens and lens care portfolio helps
more patients see, look and feel their best
Surface &
Solutions
Material &
Manufacturing
Optical
Color
Unique Technology Platforms
11 | Alcon Corporate Presentation | July 2016 | Business Use Only
Our scientists and leaders frequently observe surgeries
and visit clinics to get real-world insights
We meet with eye care practitioners regularly to gain
feedback and insights on our products and future needs
We’ve awarded $22+ million in research grants over 35
years
Partnering with eye care professionals to advance
patient care
12 | Alcon Corporate Presentation | July 2016 | Business Use Only
Helping our customers continuously learn and improve
patient outcomes
Grants
$58 million in Independent
Medical Education (IME)
grants since 2010
How many?
Facilities
30+ state-of-the-art,
interactive training centers
around the world
Programs
Digital and event-based
training for practitioners,
students, residents, patients
and consumers
13 | Alcon Corporate Presentation | July 2016 | Business Use Only
Partner
with org’s that provide
access to quality,
sustainable eye care
Advocate
for quality eye care
around the world
Engage
associates through
serving our
communities
Support
eye care professionals
in enhancing sight for
those in need
50+ years of creating sustainable access to eye care
14 | Alcon Corporate Presentation | July 2016 | Business Use Only
This commitment translates into an
annual investment of...
$5 million in cash grants
Product donations for 600
missions that serve 400,000+
patients in 80 countries
15 | Alcon Corporate Presentation | July 2016 | Business Use Only
Connect with Alcon!
Alcon.com
Company info, stories, educational materials,
job postings, media center, locations
facebook.com/AlconEyeCare
Eye health information and trivia; news from
around Alcon
Linkedin.com
Interesting information on Alcon’s business, how
we operate and career opportunities
Alcon Corporate Presentation - short edition Sept 2016

Contenu connexe

Tendances

Non proliferative diabetic retinopathy by phaneendra akana
Non proliferative diabetic retinopathy by phaneendra akanaNon proliferative diabetic retinopathy by phaneendra akana
Non proliferative diabetic retinopathy by phaneendra akanaMohan Phaneendra Akana
 
School Sight Testing Program
School Sight Testing ProgramSchool Sight Testing Program
School Sight Testing ProgramDr. A Huq
 
Differential diagnosis retina
Differential diagnosis   retinaDifferential diagnosis   retina
Differential diagnosis retinadrkvasantha
 
Primary level eyecare services
Primary level eyecare servicesPrimary level eyecare services
Primary level eyecare servicesHossein Mirzaie
 
Contact lens complication
Contact lens complication Contact lens complication
Contact lens complication Noor Munirah Aab
 
Concussions, TBI, Reading, Balance, Car-Sickness, Attention, Visual Fatigue P...
Concussions, TBI, Reading, Balance, Car-Sickness, Attention, Visual Fatigue P...Concussions, TBI, Reading, Balance, Car-Sickness, Attention, Visual Fatigue P...
Concussions, TBI, Reading, Balance, Car-Sickness, Attention, Visual Fatigue P...Visionary Ophthamology
 
Orthoptic evaluation 1
Orthoptic evaluation 1Orthoptic evaluation 1
Orthoptic evaluation 1Pushkar Dhir
 
Scleral buckling for rhegmatogenous retinal detachment
Scleral buckling for rhegmatogenous retinal detachmentScleral buckling for rhegmatogenous retinal detachment
Scleral buckling for rhegmatogenous retinal detachmentreboca smith
 
Pseudophakic Bullous Keratopathy case
Pseudophakic Bullous Keratopathy case Pseudophakic Bullous Keratopathy case
Pseudophakic Bullous Keratopathy case Noor Munirah Aab
 
Management of visual problems of Aging by Ashith Tripathi
Management of visual problems of Aging   by Ashith Tripathi Management of visual problems of Aging   by Ashith Tripathi
Management of visual problems of Aging by Ashith Tripathi Ashith Tripathi
 
FDA classification of soft contact lens
FDA classification of soft contact lensFDA classification of soft contact lens
FDA classification of soft contact lenssushmitha hebri
 
Stromal and endothelial dystrophies ppt
Stromal and endothelial dystrophies  pptStromal and endothelial dystrophies  ppt
Stromal and endothelial dystrophies pptHarshitha KM
 
Ophthalmology basic science MCQs & Answers
Ophthalmology basic science MCQs & AnswersOphthalmology basic science MCQs & Answers
Ophthalmology basic science MCQs & AnswersRiyad Banayot
 
CASE PRESENTATION BV
CASE PRESENTATION BVCASE PRESENTATION BV
CASE PRESENTATION BVMIKAH TCHALE
 
evaluation of strabismus
evaluation of strabismusevaluation of strabismus
evaluation of strabismusSudheer Kumar
 
Anatomy of crystalline lens by Dr. Aayush Tandon
Anatomy of crystalline lens by Dr. Aayush Tandon Anatomy of crystalline lens by Dr. Aayush Tandon
Anatomy of crystalline lens by Dr. Aayush Tandon Aayush Tandon
 

Tendances (20)

Non proliferative diabetic retinopathy by phaneendra akana
Non proliferative diabetic retinopathy by phaneendra akanaNon proliferative diabetic retinopathy by phaneendra akana
Non proliferative diabetic retinopathy by phaneendra akana
 
School Sight Testing Program
School Sight Testing ProgramSchool Sight Testing Program
School Sight Testing Program
 
Differential diagnosis retina
Differential diagnosis   retinaDifferential diagnosis   retina
Differential diagnosis retina
 
Primary level eyecare services
Primary level eyecare servicesPrimary level eyecare services
Primary level eyecare services
 
Contact lens complication
Contact lens complication Contact lens complication
Contact lens complication
 
Concussions, TBI, Reading, Balance, Car-Sickness, Attention, Visual Fatigue P...
Concussions, TBI, Reading, Balance, Car-Sickness, Attention, Visual Fatigue P...Concussions, TBI, Reading, Balance, Car-Sickness, Attention, Visual Fatigue P...
Concussions, TBI, Reading, Balance, Car-Sickness, Attention, Visual Fatigue P...
 
Retina
RetinaRetina
Retina
 
Aphakia
AphakiaAphakia
Aphakia
 
Orthoptic evaluation 1
Orthoptic evaluation 1Orthoptic evaluation 1
Orthoptic evaluation 1
 
Corneal transparency
Corneal transparencyCorneal transparency
Corneal transparency
 
Scleral buckling for rhegmatogenous retinal detachment
Scleral buckling for rhegmatogenous retinal detachmentScleral buckling for rhegmatogenous retinal detachment
Scleral buckling for rhegmatogenous retinal detachment
 
Pseudophakic Bullous Keratopathy case
Pseudophakic Bullous Keratopathy case Pseudophakic Bullous Keratopathy case
Pseudophakic Bullous Keratopathy case
 
Management of visual problems of Aging by Ashith Tripathi
Management of visual problems of Aging   by Ashith Tripathi Management of visual problems of Aging   by Ashith Tripathi
Management of visual problems of Aging by Ashith Tripathi
 
Anisometropia
Anisometropia Anisometropia
Anisometropia
 
FDA classification of soft contact lens
FDA classification of soft contact lensFDA classification of soft contact lens
FDA classification of soft contact lens
 
Stromal and endothelial dystrophies ppt
Stromal and endothelial dystrophies  pptStromal and endothelial dystrophies  ppt
Stromal and endothelial dystrophies ppt
 
Ophthalmology basic science MCQs & Answers
Ophthalmology basic science MCQs & AnswersOphthalmology basic science MCQs & Answers
Ophthalmology basic science MCQs & Answers
 
CASE PRESENTATION BV
CASE PRESENTATION BVCASE PRESENTATION BV
CASE PRESENTATION BV
 
evaluation of strabismus
evaluation of strabismusevaluation of strabismus
evaluation of strabismus
 
Anatomy of crystalline lens by Dr. Aayush Tandon
Anatomy of crystalline lens by Dr. Aayush Tandon Anatomy of crystalline lens by Dr. Aayush Tandon
Anatomy of crystalline lens by Dr. Aayush Tandon
 

En vedette

PUBLIC MARKET TRENDS IN OPHTHALMOLOGY
PUBLIC MARKET TRENDS IN OPHTHALMOLOGYPUBLIC MARKET TRENDS IN OPHTHALMOLOGY
PUBLIC MARKET TRENDS IN OPHTHALMOLOGYHealthegy
 
Sales Management - Bausch & Lomb
Sales Management - Bausch & LombSales Management - Bausch & Lomb
Sales Management - Bausch & LombAlexandra H.
 
A View of The Public Ophthalmology Market & Exit Trends
A View of The Public Ophthalmology Market & Exit TrendsA View of The Public Ophthalmology Market & Exit Trends
A View of The Public Ophthalmology Market & Exit TrendsHealthegy
 
TRENDS IN PRIVATE COMPANY FINANCING & EXITS IN OPHTHALMOLOGY
TRENDS IN PRIVATE COMPANY FINANCING & EXITS IN OPHTHALMOLOGYTRENDS IN PRIVATE COMPANY FINANCING & EXITS IN OPHTHALMOLOGY
TRENDS IN PRIVATE COMPANY FINANCING & EXITS IN OPHTHALMOLOGYHealthegy
 
37279739 bausch-and-lomb-case-study
37279739 bausch-and-lomb-case-study37279739 bausch-and-lomb-case-study
37279739 bausch-and-lomb-case-studyNady Khan
 
RETINA COMPANY SHOWCASE - Bausch + Lomb
RETINA COMPANY SHOWCASE - Bausch + LombRETINA COMPANY SHOWCASE - Bausch + Lomb
RETINA COMPANY SHOWCASE - Bausch + LombHealthegy
 
Nestlé and Alcon, The Value of a listing - DDIM2011 Shanghai - group 9
 Nestlé and Alcon, The Value of a listing - DDIM2011 Shanghai - group 9 Nestlé and Alcon, The Value of a listing - DDIM2011 Shanghai - group 9
Nestlé and Alcon, The Value of a listing - DDIM2011 Shanghai - group 9Vito
 
Opthalmology market an oppertunity and overview 1
Opthalmology market   an oppertunity and overview 1Opthalmology market   an oppertunity and overview 1
Opthalmology market an oppertunity and overview 1Ishan Shukla
 
Cryotherapy in Ophthalmology
Cryotherapy in OphthalmologyCryotherapy in Ophthalmology
Cryotherapy in OphthalmologyDevanshu Arora
 
Ophthalmology instruments ophthalmology ppt
Ophthalmology instruments ophthalmology pptOphthalmology instruments ophthalmology ppt
Ophthalmology instruments ophthalmology pptTONY SCARIA
 
M.Small Alcon MBA Project
M.Small Alcon MBA ProjectM.Small Alcon MBA Project
M.Small Alcon MBA ProjectMSmall2009
 

En vedette (13)

Presentation5
Presentation5Presentation5
Presentation5
 
PUBLIC MARKET TRENDS IN OPHTHALMOLOGY
PUBLIC MARKET TRENDS IN OPHTHALMOLOGYPUBLIC MARKET TRENDS IN OPHTHALMOLOGY
PUBLIC MARKET TRENDS IN OPHTHALMOLOGY
 
Sales Management - Bausch & Lomb
Sales Management - Bausch & LombSales Management - Bausch & Lomb
Sales Management - Bausch & Lomb
 
A View of The Public Ophthalmology Market & Exit Trends
A View of The Public Ophthalmology Market & Exit TrendsA View of The Public Ophthalmology Market & Exit Trends
A View of The Public Ophthalmology Market & Exit Trends
 
TRENDS IN PRIVATE COMPANY FINANCING & EXITS IN OPHTHALMOLOGY
TRENDS IN PRIVATE COMPANY FINANCING & EXITS IN OPHTHALMOLOGYTRENDS IN PRIVATE COMPANY FINANCING & EXITS IN OPHTHALMOLOGY
TRENDS IN PRIVATE COMPANY FINANCING & EXITS IN OPHTHALMOLOGY
 
37279739 bausch-and-lomb-case-study
37279739 bausch-and-lomb-case-study37279739 bausch-and-lomb-case-study
37279739 bausch-and-lomb-case-study
 
RETINA COMPANY SHOWCASE - Bausch + Lomb
RETINA COMPANY SHOWCASE - Bausch + LombRETINA COMPANY SHOWCASE - Bausch + Lomb
RETINA COMPANY SHOWCASE - Bausch + Lomb
 
Nestlé and Alcon, The Value of a listing - DDIM2011 Shanghai - group 9
 Nestlé and Alcon, The Value of a listing - DDIM2011 Shanghai - group 9 Nestlé and Alcon, The Value of a listing - DDIM2011 Shanghai - group 9
Nestlé and Alcon, The Value of a listing - DDIM2011 Shanghai - group 9
 
Opthalmology market an oppertunity and overview 1
Opthalmology market   an oppertunity and overview 1Opthalmology market   an oppertunity and overview 1
Opthalmology market an oppertunity and overview 1
 
Cryotherapy in Ophthalmology
Cryotherapy in OphthalmologyCryotherapy in Ophthalmology
Cryotherapy in Ophthalmology
 
Ophthalmology instruments ophthalmology ppt
Ophthalmology instruments ophthalmology pptOphthalmology instruments ophthalmology ppt
Ophthalmology instruments ophthalmology ppt
 
Nestlé and Alcon -case
Nestlé and Alcon -caseNestlé and Alcon -case
Nestlé and Alcon -case
 
M.Small Alcon MBA Project
M.Small Alcon MBA ProjectM.Small Alcon MBA Project
M.Small Alcon MBA Project
 

Similaire à Alcon Corporate Presentation - short edition Sept 2016

Regulatory AgencyHCS430 Version 81University of Phoenix M.docx
Regulatory AgencyHCS430 Version 81University of Phoenix M.docxRegulatory AgencyHCS430 Version 81University of Phoenix M.docx
Regulatory AgencyHCS430 Version 81University of Phoenix M.docxsodhi3
 
Maxvue vision Contact lens manufacturer profile
Maxvue vision Contact lens manufacturer profileMaxvue vision Contact lens manufacturer profile
Maxvue vision Contact lens manufacturer profileSelvam Kanniah
 
Nivedita :vasan eye care
Nivedita  :vasan eye careNivedita  :vasan eye care
Nivedita :vasan eye carenivedita212
 
Nivedita vasan eye care
Nivedita vasan eye careNivedita vasan eye care
Nivedita vasan eye carenivtrip
 
Optometry2017 brochure
Optometry2017 brochureOptometry2017 brochure
Optometry2017 brochureLisa Anderson
 
2015-16 Annual Review - final low res
2015-16 Annual Review - final low res2015-16 Annual Review - final low res
2015-16 Annual Review - final low resKirsty Jerome
 
Sight first anup zimba
Sight first anup zimbaSight first anup zimba
Sight first anup zimbalionsleaders
 
Lions siliguri greater hospital
Lions siliguri greater hospitalLions siliguri greater hospital
Lions siliguri greater hospitallionsleaders
 
Aravind Eye Care- CSR Initiative
Aravind Eye Care- CSR InitiativeAravind Eye Care- CSR Initiative
Aravind Eye Care- CSR InitiativeHetang Desai
 
Zava - NOAH19 London
Zava - NOAH19 LondonZava - NOAH19 London
Zava - NOAH19 LondonNOAH Advisors
 
Npcb by pushkar dhir
Npcb by pushkar dhirNpcb by pushkar dhir
Npcb by pushkar dhirPushkar Dhir
 
AXA Mansard Insurance annual report 2016
AXA Mansard Insurance annual report 2016AXA Mansard Insurance annual report 2016
AXA Mansard Insurance annual report 2016Michael Olafusi
 
Marketing Healthcare Services Discussion.pdf
Marketing Healthcare Services Discussion.pdfMarketing Healthcare Services Discussion.pdf
Marketing Healthcare Services Discussion.pdfbkbk37
 
2013 05 24 - luxottica corporate presentation
2013 05 24 - luxottica corporate  presentation2013 05 24 - luxottica corporate  presentation
2013 05 24 - luxottica corporate presentationJenny Tang
 
Operation eyesight
Operation eyesightOperation eyesight
Operation eyesightlionsleaders
 
Dossier de presse - IMCAS - janvier 2015
Dossier de presse - IMCAS - janvier 2015Dossier de presse - IMCAS - janvier 2015
Dossier de presse - IMCAS - janvier 2015pbcom1998
 
S w W11212 ARAVIND EYE CARE SYSTEM PROVIDING .docx
S w  W11212    ARAVIND EYE CARE SYSTEM PROVIDING .docxS w  W11212    ARAVIND EYE CARE SYSTEM PROVIDING .docx
S w W11212 ARAVIND EYE CARE SYSTEM PROVIDING .docxanhlodge
 

Similaire à Alcon Corporate Presentation - short edition Sept 2016 (20)

EVP
EVPEVP
EVP
 
Regulatory AgencyHCS430 Version 81University of Phoenix M.docx
Regulatory AgencyHCS430 Version 81University of Phoenix M.docxRegulatory AgencyHCS430 Version 81University of Phoenix M.docx
Regulatory AgencyHCS430 Version 81University of Phoenix M.docx
 
Maxvue vision Contact lens manufacturer profile
Maxvue vision Contact lens manufacturer profileMaxvue vision Contact lens manufacturer profile
Maxvue vision Contact lens manufacturer profile
 
Nivedita :vasan eye care
Nivedita  :vasan eye careNivedita  :vasan eye care
Nivedita :vasan eye care
 
Nivedita vasan eye care
Nivedita vasan eye careNivedita vasan eye care
Nivedita vasan eye care
 
Optometry2017 brochure
Optometry2017 brochureOptometry2017 brochure
Optometry2017 brochure
 
2015-16 Annual Review - final low res
2015-16 Annual Review - final low res2015-16 Annual Review - final low res
2015-16 Annual Review - final low res
 
Sight first anup zimba
Sight first anup zimbaSight first anup zimba
Sight first anup zimba
 
Lions siliguri greater hospital
Lions siliguri greater hospitalLions siliguri greater hospital
Lions siliguri greater hospital
 
Aravind Eye Care- CSR Initiative
Aravind Eye Care- CSR InitiativeAravind Eye Care- CSR Initiative
Aravind Eye Care- CSR Initiative
 
Zava - NOAH19 London
Zava - NOAH19 LondonZava - NOAH19 London
Zava - NOAH19 London
 
Npcb by pushkar dhir
Npcb by pushkar dhirNpcb by pushkar dhir
Npcb by pushkar dhir
 
AXA Mansard Insurance annual report 2016
AXA Mansard Insurance annual report 2016AXA Mansard Insurance annual report 2016
AXA Mansard Insurance annual report 2016
 
Marketing Healthcare Services Discussion.pdf
Marketing Healthcare Services Discussion.pdfMarketing Healthcare Services Discussion.pdf
Marketing Healthcare Services Discussion.pdf
 
2013 05 24 - luxottica corporate presentation
2013 05 24 - luxottica corporate  presentation2013 05 24 - luxottica corporate  presentation
2013 05 24 - luxottica corporate presentation
 
Operation eyesight
Operation eyesightOperation eyesight
Operation eyesight
 
Dossier de presse - IMCAS - janvier 2015
Dossier de presse - IMCAS - janvier 2015Dossier de presse - IMCAS - janvier 2015
Dossier de presse - IMCAS - janvier 2015
 
Halton ccg (rh)
Halton ccg (rh)Halton ccg (rh)
Halton ccg (rh)
 
S w W11212 ARAVIND EYE CARE SYSTEM PROVIDING .docx
S w  W11212    ARAVIND EYE CARE SYSTEM PROVIDING .docxS w  W11212    ARAVIND EYE CARE SYSTEM PROVIDING .docx
S w W11212 ARAVIND EYE CARE SYSTEM PROVIDING .docx
 
press release 2016
press release 2016press release 2016
press release 2016
 

Alcon Corporate Presentation - short edition Sept 2016

  • 2. 2 | Alcon Corporate Presentation | July 2016 | Business Use Only Why We Exist 20 million are blind from cataracts 1.7 billion have presbyopia 93 million have diabetic retinopathy 67 million live with glaucoma 153 million have uncorrected refractive errors
  • 3. 3 | Alcon Corporate Presentation | July 2016 | Business Use Only We operate in 74 and serve patients in over 140 countries • Fort Worth, TX, US: Global, Americas • Switzerland: Europe, Middle East and Africa • Singapore: Asia & Russia • Japan Headquarters • US: Georgia and Texas • Europe: Germany • Asia: Singapore, Malaysia, Indonesia Vision Care R&D and Manufacturing • US: California, Texas, Pennsylvania, West Virginia • Europe: Switzerland, Germany, Ireland, Belgium • Israel Surgical R&D and Manufacturing
  • 4. 4 | Alcon Corporate Presentation | July 2016 | Business Use Only We are 16,000 people strong Our workforce comprises individuals from 96 nationalities Our Values and Behaviors guide the choices we make and actions we take: innovation, quality, collaboration, performance, courage and integrity We create meaningful opportunities for associates to grow their careers
  • 5. 5 | Alcon Corporate Presentation | July 2016 | Business Use Only Discovering new ways to enhance sight for nearly 70 years 1994 AcrySof® 2000 20112007 WaveLight®1947 Alcon incorporates 2010 LenSx® 2014 1989 CooperVision surgical 2012 / 2013 DAILIES TOTAL1® and Centurion® 2015 PanOptix® and UltraSert® 2016 CyPass ® and NGenuity ® 1996 FOCUS® DAILIES® 2004 O2OPTIX ® (re-branded as AIR OPTIX® in 2008)
  • 6. 6 | Alcon Corporate Presentation | July 2016 | Business Use Only In 2015, we reached more than 260 million patients but there are still 285 million living with low vision and blindness Reimagining eye care to address growing patient needs Aging population with growing unmet needs Scientific & technological innovation are improving outcomes Our vision is to be the trusted leader in eye care Our mission is to discover new ways to enhance sight and improve people’s lives
  • 7. 7 | Alcon Global Webcast | May 2016 | Business Use Only The Alcon Experience Standards Our guiding principles to delight our customers at every touch point Patients and Consumers First Partnership Expertise
  • 8. 8 | Alcon Corporate Presentation | July 2016 | Business Use Only Together with Novartis, we offer the widest spectrum of products in eye care Treating the entire eye Cornea / front of eye Refractive errors, inflammation, infection, dry eye, allergy Lens Cataract, presbyopia Optic nerve Glaucoma Retina / back of eye Vitreoretinal / retinal diseases And the full lifecycle of eye care needs Infants Children Teenagers Age 60 and up Age 40-59 Age 20-39
  • 9. 9 | Alcon Corporate Presentation | July 2016 | Business Use Only Most complete line of ophthalmic surgical devices #1 Intraocular Lenses #1 Cataract Equipment #1 Vitreoretinal Equipment #2 Refractive Equipment New category: Surgical Glaucoma AcrySof® IOLs • 90 mil implants since 1994 • Astigmatism and presbyopia correction • PanOptix® trifocal IOL • UltraSert® Pre- loaded IOL Delivery System Cataract Refractive Suite for superior outcomes • Centurion® • LenSx® • Verion® • ORA System® • LuxOR® • Consumables Constellation® Vision System to effectively treat retinal conditions • Superior instruments and consumables • NGENUITY® 3D Visualization System Wavelight® diagnoses and corrects myopia, hyperopia and astigmatism • Contoura™ Vision Topography-Guided primary LASIK treatments CyPass® minimally- invasive micro-stent to treat glaucoma • CE Mark in Europe; FDA approved
  • 10. 10 | Alcon Corporate Presentation | July 2016 | Business Use Only Differentiated contact lens and lens care portfolio helps more patients see, look and feel their best Surface & Solutions Material & Manufacturing Optical Color Unique Technology Platforms
  • 11. 11 | Alcon Corporate Presentation | July 2016 | Business Use Only Our scientists and leaders frequently observe surgeries and visit clinics to get real-world insights We meet with eye care practitioners regularly to gain feedback and insights on our products and future needs We’ve awarded $22+ million in research grants over 35 years Partnering with eye care professionals to advance patient care
  • 12. 12 | Alcon Corporate Presentation | July 2016 | Business Use Only Helping our customers continuously learn and improve patient outcomes Grants $58 million in Independent Medical Education (IME) grants since 2010 How many? Facilities 30+ state-of-the-art, interactive training centers around the world Programs Digital and event-based training for practitioners, students, residents, patients and consumers
  • 13. 13 | Alcon Corporate Presentation | July 2016 | Business Use Only Partner with org’s that provide access to quality, sustainable eye care Advocate for quality eye care around the world Engage associates through serving our communities Support eye care professionals in enhancing sight for those in need 50+ years of creating sustainable access to eye care
  • 14. 14 | Alcon Corporate Presentation | July 2016 | Business Use Only This commitment translates into an annual investment of... $5 million in cash grants Product donations for 600 missions that serve 400,000+ patients in 80 countries
  • 15. 15 | Alcon Corporate Presentation | July 2016 | Business Use Only Connect with Alcon! Alcon.com Company info, stories, educational materials, job postings, media center, locations facebook.com/AlconEyeCare Eye health information and trivia; news from around Alcon Linkedin.com Interesting information on Alcon’s business, how we operate and career opportunities

Notes de l'éditeur

  1. 20 million blind from cataracts: World Health Organization 1.7 billion have presbyopia: Market Scope 153 million have uncorrected refractive errors: World Health Organization 93 million have diabetic retinopathy: National Center for Biotechnology Information 67 million have glaucoma: Glaucoma Foundation
  2. Over the past 70 years, we’ve developed innovative products, made strategic acquisitions and partnered with key third-party organizations to become the world’s leader in eye care.
  3. 285 million living with low vision and blindness: World Health Organization
  4. Alcon is organized into three business franchises: surgical, pharmaceutical and vision care. We offer the industry’s most complete line of ophthalmic surgical products, a broad range of high-quality pharmaceutical products and a comprehensive portfolio of contact lenses and contact lens care solutions. Alcon’s Surgical portfolio includes technologies and devices for cataract, retinal and glaucoma surgery, as well as Lasik surgery for the treatment of refractive errors, like presbyopia and astigmatism. Our Pharmaceutical portfolio includes the leading treatments for people with glaucoma, eye infections and inflammation, ocular allergies, dry eye, and ear infections. Through the integration of CIBA VISION, the Alcon Vision Care franchise is now one of the largest manufacturers of contact lenses and lens care products. Our three businesses contributed to global sales in the US of $10.7B in 2014.
  5. The Alcon Foundation funds programs to increase the number of well-trained eye care professionals, enhance access to eye care, particularly in emerging countries and our local communities, as well as improve awareness of eye health. Through our relationships with non-profit organizations and ophthalmologists who volunteer as part of medical missions, The Alcon Foundation supports multiple programs offering cash grants and product donations. Alcon also runs a patient assistance program in the United States to provide patient access to quality eye care no matter their economic means.